Developments in gastrointestinal tumour treatment

Polycomb repressors and epigenetic therapy

DNA repair and mutations as targets for personalised therapy

The changing process of drug discovery and design

Glioblastoma heterogeneity in circulating tumour DNA

Connections in cancer-host immune signalling

Targeting and imaging invasion and metastasis

Advances in early detection

Polygenic risk and the targeted prevention of cancer

Understanding mutational processes in human cancer

Changing landscape of multiple myeloma care: Expert discussion

Models and critical preclinical data shaping personal therapy